Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk

被引：0
|
作者：
Yadong Wang
Haiyan Yang
Haiyu Wang
机构：
[1] Henan Center for Disease Control and Prevention,Department of Toxicology
[2] Zhengzhou University,Department of Epidemiology, School of Public Health
来源：
Breast Cancer Research and Treatment | 2015年 / 150卷
关键词：
Polymorphism; Breast cancer; Risk; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
With great interest, we read the recent article entitled “Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis” published online in Pabalan et al. (Breast Cancer Res Treat 137:553–558, 2013). This article suggests that overall summary estimates imply no associations but suggest susceptibility among carriers of the C47G polymorphism and Pro-Ser genotype in premenopausal women. The result is encouraging. Nevertheless, several key issues in this meta-analysis are worth noticing.
引用
收藏
页码：467 / 471
页数：4
相关论文
共 50 条
  • [31] BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer
    Weber-Lassalle, Nana
    Hauke, Jan
    Ramser, Juliane
    Richters, Lisa
    Gross, Eva
    Bluemcke, Britta
    Gehrig, Andrea
    Kahlert, Anne-Karin
    Mueller, Clemens R.
    Hackmann, Karl
    Honisch, Ellen
    Weber-Lassalle, Konstantin
    Niederacher, Dieter
    Borde, Julika
    Thiele, Holger
    Ernst, Corinna
    Altmueller, Janine
    Neidhardt, Guido
    Nuernberg, Peter
    Klaschik, Kristina
    Schroeder, Christopher
    Platzer, Konrad
    Volk, Alexander E.
    Wang-Gohrke, Shan
    Just, Walter
    Auber, Bernd
    Kubisch, Christian
    Schmidt, Gunnar
    Horvath, Judit
    Wappenschmidt, Barbara
    Engel, Christoph
    Arnold, Norbert
    Dworniczak, Bernd
    Rhiem, Kerstin
    Meindl, Alfons
    Schmutzler, Rita K.
    Hahnen, Eric
    BREAST CANCER RESEARCH, 2018, 20
  • [32] No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
    Easton, Douglas F.
    Lesueur, Fabienne
    Decker, Brennan
    Michailidou, Kyriaki
    Li, Jun
    Allen, Jamie
    Luccarini, Craig
    Pooley, Karen A.
    Shah, Mitul
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Ahmad, Jamil
    Thompson, Ella R.
    Damiola, Francesca
    Pertesi, Maroulio
    Voegele, Catherine
    Mebirouk, Noura
    Robinot, Nivonirina
    Durand, Geoffroy
    Forey, Nathalie
    Luben, Robert N.
    Ahmed, Shahana
    Aittomaki, Kristiina
    Anton-Culver, Hoda
    Arndt, Volker
    Baynes, Caroline
    Beckman, Matthias W.
    Benitez, Javier
    Van Den Berg, David
    Blot, William J.
    Bogdanova, Natalia V.
    Bojesen, Stig E.
    Brenner, Hermann
    Chang-Claude, Jenny
    Chia, Kee Seng
    Choi, Ji-Yeob
    Conroy, Don M.
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Darabi, Hatef
    Devilee, Peter
    Eriksson, Mikael
    Fasching, Peter A.
    Figueroa, Jonine
    Flyger, Henrik
    Fostira, Florentia
    Garcia-Closas, Montserrat
    Giles, Graham G.
    JOURNAL OF MEDICAL GENETICS, 2016, 53 (05) : 298 - 309
  • [33] Note of clarification regarding data about the association between the interleukin-1β −31T>C polymorphism and breast cancer risk
    Yadong Wang
    Yan Wang
    Li Li
    Breast Cancer Research and Treatment, 2016, 155 : 415 - 417
  • [34] Note of clarification regarding data on the association between the interleukin-1β-511C>T polymorphism and breast cancer risk
    Wang, Yadong
    Chu, Xinwei
    Wang, Haiyu
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 419 - 421
  • [35] BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer
    Nana Weber-Lassalle
    Jan Hauke
    Juliane Ramser
    Lisa Richters
    Eva Groß
    Britta Blümcke
    Andrea Gehrig
    Anne-Karin Kahlert
    Clemens R. Müller
    Karl Hackmann
    Ellen Honisch
    Konstantin Weber-Lassalle
    Dieter Niederacher
    Julika Borde
    Holger Thiele
    Corinna Ernst
    Janine Altmüller
    Guido Neidhardt
    Peter Nürnberg
    Kristina Klaschik
    Christopher Schroeder
    Konrad Platzer
    Alexander E. Volk
    Shan Wang-Gohrke
    Walter Just
    Bernd Auber
    Christian Kubisch
    Gunnar Schmidt
    Judit Horvath
    Barbara Wappenschmidt
    Christoph Engel
    Norbert Arnold
    Bernd Dworniczak
    Kerstin Rhiem
    Alfons Meindl
    Rita K. Schmutzler
    Eric Hahnen
    Breast Cancer Research, 20
  • [36] Identification of a novel BRIP1 germline mutation in a woman with early onset breast cancer
    Tancredi, M.
    De, Nicolo A.
    Sensi, E.
    Cipollini, G.
    Lombardi, G.
    Aretini, P.
    Barbuti, S.
    Sobhian, B.
    Bevilacqua, G.
    Drapkin, R.
    Caligo, M. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (01) : 120 - 121
  • [37] Note of clarification of data in the paper entitled no association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis
    Yang, Haiyan
    Shao, Fuye
    Wang, Haiyu
    Wang, Yadong
    TUMOR BIOLOGY, 2015, 36 (04) : 2235 - 2240
  • [38] Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer risk
    Zhai, Wenlong
    Feng, Ruo
    Yang, Haiyan
    Wang, Yadong
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1650 - 1655
  • [39] BRIP1-A risk gene for breast cancer?
    Weber-Lassalle, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 3 - 3
  • [40] Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
    Solyom, Szilvia
    Pylkas, Katri
    Winqvist, Robert
    FAMILIAL CANCER, 2010, 9 (04) : 537 - 540
12345